Pharma giant Eli Lilly confirmed plans for the plant in Houston where an oral GLP-1 weight loss drug could be made, creating ...

Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation Park, a 4,000-acre master-planned development in northeast Houston that is ...

The company says it will invest $6.5 billion in a manufacturing facility at the Generation Park complex in Houston. Lilly ...

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...

Eli Lilly has revealed it is to build an active pharmaceutical product (API) facility in Texas, US, a week after revealing ...

In a major development for the Greater Houston economy, Fortune 100 drugmaker Eli Lilly has announced plans for a $6.5 billion manufacturing facility at Generation Park in Northeast Harris County.

Eli Lilly's massive investment in Houston is even larger than it initially proposed just four months ago when it applied for ...

The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 ...

The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing ...

By Muvija M LONDON (Reuters) -Eli Lilly Chief Executive Dave Ricks said Britain was "probably the worst country in Europe" ...